FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100314 [Registered on: 05/01/2026] Trial Registered Prospectively
Last Modified On: 02/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective Observational 
Study Design  Single Arm Study 
Public Title of Study   A study to assess confusion and restlessness after general anaesthesia with sevoflurane in adults. 
Scientific Title of Study   Evaluation of incidence of sevoflurane induced emergence delirium following general anaesthesia in adults- An observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  KAVIYA T 
Designation  POSTGRADUATE M.D ANAESTHESIOLOGY 
Affiliation  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE 
Address  FLAT NO.2C, ISHA CODE FIELD APARTMENT, PUTHUPAKKAM

Kancheepuram
TAMIL NADU
603103
India 
Phone  09566242715  
Fax    
Email  kavisdoc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR VIJAY NARAYANAN S 
Designation  PROFESSOR 
Affiliation  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE 
Address  PROFESSOR, DEPARTMENT OF ANAESTHESIOLOGY, CHETTINAD HOSPITAL AND RESARCH INSTITUTE, CHETTINAD HEALTH CITY (OMR), KELAMBAKKAM

Kancheepuram
TAMIL NADU
603103
India 
Phone  7904535573  
Fax    
Email  vijaynarayanans@care.edu.in  
 
Details of Contact Person
Public Query
 
Name  DR VIJAY NARAYANAN S 
Designation  PROFESSOR 
Affiliation  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE 
Address  PROFESSOR, DEPARTMENT OF ANAESTHESIOLOGY, CHETTINAD HOSPITAL AND RESARCH INSTITUTE, CHETTINAD HEALTH CITY (OMR), KELAMBAKKAM

Kancheepuram
TAMIL NADU
603103
India 
Phone  7904535573  
Fax    
Email  vijaynarayanans@care.edu.in  
 
Source of Monetary or Material Support  
CHETTINAD HOSPITAL AND RESEARCH INSTITUTE 
 
Primary Sponsor  
Name  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE 
Address  Chettinad hospital and research institute , chettinad health city, Rajiv gandhi salai, Kelambakkam, chennai, Tamilnadu, India-603103 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR KAVIYA T  CHETTINAD HOSPITAL AND RESEARCH INSTITUTE  D-Block,1st floor, Department of Anesthesiology, chettinad health city, rajiv gandhi salai, kelambakkam
Kancheepuram
TAMIL NADU 
09566242715

kavisdoc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee for Student Research (CARE IHEC-I)(  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F40-F48||Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  SEVOFLURANE  No comparator agent (single arm observational study) 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Posted for general anesthesia
2.Only elective cases
3.Duration of surgery more than 2hours. 
 
ExclusionCriteria 
Details  1.Patients known to have preexisting diseases such as history of chronic dementia psychosis mental retardation cerebrovascular accidents with residual cognitive impairment.
2.Neurological surgeries
3.Psychiatric conditions
4.Pregnancy
5.Emergency surgery
6.Patients with BMI more than 35
7.Patient refusal.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine incidence of emergence delirium with sevoflurane in adults.  150 mins 
 
Secondary Outcome  
Outcome  TimePoints 
To identify factors associated with emergence delirium with sevoflurane in adults in perioperative period following general anesthesia  150mins 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Delirium is a disturbance of consciousness with inattention accompanied by change in cognition or perceptual disturbance that develops over a short period and fluctuates over time. Delirium during postoperative period can be divided into Emergence delirium and Postoperative delirium based on its onset. Emergence delirium or Emergence agitation or Postanesthetic excitement occurs during immediate postoperative period and lasting for 5-15mins. Emergence delirium is a clinical condition in which patients are awake but experience alterations in disorientation and other mental status changes that ranges from confusion and lethargy to violent and harmful behaviour. Emergence delirium during immediate post anesthesia period is common. It may lead to serious consequences for the patients such as injury, increased pain, hemorrhage, self Extubation, removal of catheters, and it can necessitate physically or chemically restraining the patients. Sevoflurane is an inhalational anesthetic used widely as outpatient anesthesia due to its excellent hemodynamic stability and low blood solubility, which allows rapid induction and emergence from general anesthesia, as well as control of depth of anesthesia. How ever sevoflurane is associated with higher incidence of emergence agitation in children. The rapid removal of residual anesthetics due to low blood solubility of sevoflurane has been suggested to cause emergence delirium in some patients.

To determine incidence and risk factors of emergence delirium in adults following general anesthesia. Primary objective- Incidence of emergence delirium with sevoflurane in adults. Secondary objective - To identify factors associated with emergence delirium in perioperative period.

A prospective observational study to be conducted over 1 year where procedures in specialities including general surgeries, Ent, Gynecological surgeries are performed. Informed consent will be obtained preoperatively. Detailed history and physical examination , baseline data like heart rate, blood pressure and basic investigations will be collected. An iv access with 18Giv cannula will be secured for all the patients. Premedication such as tab. Ranitidine 150mg and tab. Alprazolam 0.5mg given night before surgery and 6am on day of surgery. After shifting the patient inside OT, proper standard monitoring of spo2, NIBP, ECG, Etco2 will be established and baseline variable values will be noted before the procedure. Patient will be premedicated with inj. midazolam 0.02mg/kg iv , inj. Glycopyrolate 0.01mg/kg iv, inj. fentanyl 2mcg/kg iv then an inducing agent inj. propofol 2mg/kg iv followed by muscle relaxant inj. vecuronium 0.08mg /kg iv along with inhalational agent sevoflurane. Patient lung were ventilated using 100% oxygen to maintain etco2 from 35 to 45mmhg. Tracheal intubation will then be performed approximately 3mins after anesthesia induction by trained an anesthetist. Tracheal intubation will be done with direct laryngoscope using macintosh blade with appropriate size ET tube. ET tube will be secured at angle of mouth and et tube position confirmed with 5point auscultation method. Then pt connected to mechanical ventilator. After tracheal intubation urinary catheters were inserted in all the patients. Plane of anesthesia is maintained throughout with inhalational agent sevoflurane at 1-2%. In all patient muscle relaxation was maintained with inj. vecuronium 0.1mg/kg iv. At the conclusion of procedure, the inhaled agents were discontinued and the fresh gas flow was maintained with 6L of oxygen. Patient given adequate analgesics. By the end of procedure Extubation done with reversal agent inj. Myopyrolate iv according to patient requirement. ET tube was removed when tidal volume >5ml/kg , respiratory rate >12 cpm, the swallowing and cough reflex were active and spo2 maintained at >95% for five minutes on room air. Pain was assessed after tracheal extubation and reassessed after ten minutes on numerical rating scale. we used the Rikers sedation agitation scale which was developed to assess the level of agitation and sedation from the time of turning off sevoflurane, during extubation and immediate post anesthesia period (5-15mins). We divided the patient in to two categories using Riker sedation scale: Non agitated patients (levels 1- 4) and agitated patients (level: 5-7). We then subdivided those patients in agitated group as agitated, very agitated, and dangerously agitated. Agitation was correlated with following factors: 1. age 2. gender 3. duration of surgery 4. comorbidities 5. alcoholism 6. postop pain. Emergence delirium is often treated with combination of Non pharmacological and pharmacological interventions. Non pharmacological strategies include reassuring the patient, managing pain with analgesics. Pharmacological options which include administering intravenous bolus of sedative agents like midazolam (0.03-0.1mg/kg iv) or propofol (0.5- 1mg/kg iv) or opioids like fentanyl (0.5-1mcg/kg iv) are used. Other drugs used in treating emergence delirium are ketamine ( 0.25mg/kg iv), Dexmedetomidine (0.3- 1 mcg/kg iv), clonidine (2-3mcg/kg iv).

REFERENCES- 

Yu D., Chai W., Sun X., et al. Emergence agitation in adults: risk factors in 2000 patients. Can J Anesth. 2010;57:843–848. doi: 10.1007/s12630-010-9338-9. 

Lepouse C., Lautner C.A., Liu L., et al. Emergence delirium in adults in the post-anesthesia care unit. Br J Anaesth. 2006;96:747–753. doi: 10.1093/bja/ael094.

Scott G.M., Gold J.I. Emergence delirium: a re-emerging interest. Sem Anesth Perioperat Pain Med. 2006;25:100–104.

G.L., Nejad S.H., Esses J.A., et al. Postoperative delirium. Am J Psychiatry. 2008;165:803–812. doi: 10.1176/appi.ajp.2008.08020181. Fricchione

 
Close